The first Cellular Biomedicine Group trade was made in Q1 2019.
Since then Cathie Wood bought shares two more times and sold shares on three occasions. The investor completely sold their stake between Q3 2020 and Q4 2020.
Avg closing price
Price range
Sold -71 Thousand shares
Q4 2020
Avg closing price
$18.22
Price range
$17.15
-
$18.70
Sold 88.2% shares (-531 Thousand shares)
Q3 2020
Avg closing price
$16.81
Price range
$13.17
-
$19.27
Increased shares by 50.6% (+202 Thousand shares)
Q2 2020
Avg closing price
$14.28
Price range
$12.15
-
$16.00
Sold 3.0% shares (-12.2 Thousand shares)
Q1 2020
Avg closing price
$16.16
Price range
$11.51
-
$17.64
Increased shares by 44.1% (+126 Thousand shares)
Q4 2019